Lista de obras -

A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.

artículo científico publicado en 2015

Autoantibody profiling in multiple sclerosis reveals novel antigenic candidates

artículo científico publicado en 2008

Autoantigen induced clonal expansion in immortalized B cells from the peripheral blood of multiple sclerosis patients

artículo científico publicado en 2013

B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions

artículo científico publicado en 2015

Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis

artículo científico publicado en 2013

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

artículo científico publicado en 2014

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

artículo científico publicado en 2016

Comparative efficacy of switching to natalizumab in active multiple sclerosis

artículo científico publicado en 2015

Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study

artículo científico publicado en 2014

Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level

scientific article published on 25 September 2007

Contribution of different relapse phenotypes to disability in multiple sclerosis.

artículo científico publicado en 2016

Defining reliable disability outcomes in multiple sclerosis.

artículo científico publicado en 2015

Defining secondary progressive multiple sclerosis

artículo científico publicado en 2016

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

artículo científico publicado en 2016

Drug adherence and multidisciplinary care in patients with multiple sclerosis: protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study)

artículo científico publicado en 2011

Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

artículo científico publicado en 2011

Effects of vitamin D on the peripheral adaptive immune system: a review

artículo científico publicado en 2011

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial

artículo científico

Evaluating the safety of β-interferons in MS: A series of nested case-control studies

artículo científico publicado en 2017

Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.

artículo científico publicado en 2017

Fatigue and physical disability in patients with multiple sclerosis: a structural equation modeling approach

artículo científico publicado en 2010

Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions

artículo científico publicado en 2014

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.

artículo científico publicado en 2014

Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.

artículo científico publicado en 2009

Geographical variations in sex ratio trends over time in multiple sclerosis.

artículo científico publicado en 2012

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

artículo científico publicado en 2016

Illuminating vitamin D effects on B cells--the multiple sclerosis perspective

artículo científico

Illuminating vitamin D effects on B-cells - the multiple sclerosis perspective

artículo científico

Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study

artículo científico publicado en 2016

Increasing age at disability milestones among MS patients in the MSBase Registry

artículo científico

Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited

artículo científico publicado en 2012

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

artículo científico publicado en 2017

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

artículo científico publicado en 2015

Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis

artículo científico publicado en 2003

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry

artículo científico publicado en 2015

Network of nuclear receptor ligands in multiple sclerosis: Common pathways and interactions of sex-steroids, corticosteroids and vitamin D3-derived molecules

artículo científico publicado en 2016

Persistence and adherence in multiple sclerosis patients starting glatiramer acetate treatment: assessment of relationship with care received from multiple disciplines

artículo científico publicado en 2016

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

artículo científico publicado en 2013

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

artículo científico publicado en 2013

Predictors of disability worsening in clinically isolated syndrome.

artículo científico publicado en 2015

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

artículo científico publicado en 2013

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.

artículo científico publicado en 2015

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.

artículo científico publicado en 2016

Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission

artículo científico publicado en 2011

Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.

artículo científico publicado en 2010

Risk of relapse phenotype recurrence in multiple sclerosis.

artículo científico publicado en 2014

Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis

artículo científico publicado en 2010

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

artículo científico publicado en 2014

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

artículo científico publicado en 2013

Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse

artículo científico publicado en 2011

The STAR Study: a real-world, international, observational study of the safety and tolerability of, and adherence to, serum-free subcutaneous interferon β-1a in patients with relapsing multiple sclerosis.

artículo científico

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

artículo científico publicado en 2015

The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis

artículo científico publicado en 2016

The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review

artículo científico publicado en 2005

The psychology of fatigue in patients with multiple sclerosis: a review

artículo científico publicado en 2008

The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis

artículo científico publicado en 2009

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

artículo científico publicado en 2017

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

artículo científico publicado en 2017

Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up

artículo científico publicado en 2016

Vitamin D as an immune modulator in multiple sclerosis, a review

scientific article published on 04 January 2008

Vitamin D effects on B cell function in autoimmunity

artículo científico

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis

artículo científico publicado en 2009

Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.

artículo científico publicado en 2011

Vitamin D3 supplementation and the IL-2/IL-2R pathway in multiple sclerosis: Attenuation of progressive disturbances?

artículo científico publicado en 2017

Vitamin D3 supplementation in multiple sclerosis: Symptoms and biomarkers of depression

artículo científico publicado en 2017

Lista de obras de

A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.

Autoantibody profiling in multiple sclerosis reveals novel antigenic candidates

Autoantigen induced clonal expansion in immortalized B cells from the peripheral blood of multiple sclerosis patients

B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions

Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

Comparative efficacy of switching to natalizumab in active multiple sclerosis

Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study

Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level

Contribution of different relapse phenotypes to disability in multiple sclerosis.

Defining reliable disability outcomes in multiple sclerosis.

Defining secondary progressive multiple sclerosis

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

Drug adherence and multidisciplinary care in patients with multiple sclerosis: protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study)

Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

Effects of vitamin D on the peripheral adaptive immune system: a review

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial

Evaluating the safety of β-interferons in MS: A series of nested case-control studies

Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.

Fatigue and physical disability in patients with multiple sclerosis: a structural equation modeling approach

Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.

Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.

Geographical variations in sex ratio trends over time in multiple sclerosis.

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Illuminating vitamin D effects on B cells--the multiple sclerosis perspective

Illuminating vitamin D effects on B-cells - the multiple sclerosis perspective

Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study

Increasing age at disability milestones among MS patients in the MSBase Registry

Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry

Network of nuclear receptor ligands in multiple sclerosis: Common pathways and interactions of sex-steroids, corticosteroids and vitamin D3-derived molecules

Persistence and adherence in multiple sclerosis patients starting glatiramer acetate treatment: assessment of relationship with care received from multiple disciplines

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

Predictors of disability worsening in clinically isolated syndrome.

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.

Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission

Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.

Risk of relapse phenotype recurrence in multiple sclerosis.

Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse

The STAR Study: a real-world, international, observational study of the safety and tolerability of, and adherence to, serum-free subcutaneous interferon β-1a in patients with relapsing multiple sclerosis.

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis

The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review

The psychology of fatigue in patients with multiple sclerosis: a review

The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up

Vitamin D as an immune modulator in multiple sclerosis, a review

Vitamin D effects on B cell function in autoimmunity

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis

Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.

Vitamin D3 supplementation and the IL-2/IL-2R pathway in multiple sclerosis: Attenuation of progressive disturbances?

Vitamin D3 supplementation in multiple sclerosis: Symptoms and biomarkers of depression